| 注册
首页|期刊导航|中国药业|经皮冠状动脉介入术中冠脉应用替罗非班临床评价

经皮冠状动脉介入术中冠脉应用替罗非班临床评价

赵娟

中国药业2017,Vol.26Issue(14):61-63,3.
中国药业2017,Vol.26Issue(14):61-63,3.DOI:10.3969/j.issn.1006-4931.2017.14.022

经皮冠状动脉介入术中冠脉应用替罗非班临床评价

Clinical Evaluation of Tirofiban Used in Coronary During Percutaneous Coronary Intervention

赵娟1

作者信息

  • 1. 河南省新乡市第一人民医院,河南 新乡 453000
  • 折叠

摘要

Abstract

Objective To investigate the effect of tirofiban on the degree of myocardial perfusion and cardiac function after percutaneous coronary intervention(PCI)in patients with myocardial infarction(MI). Methods Totally 76 patients with MI underwent PCI in the hospital from February 2014 to March 2016 were selected,all patients were treated with tirofiban during PCI,and all patients underwent color doppler ultrasonography after operation. 42 patients with myocardial perfusion Ⅰand Ⅱwere enrolled in the study group,and 34 patients with myocardial perfusion grade 0 were enrolled in the control group. The cardiac function indexes of the two groups were compared. Results 7 d and 3 months after operation, the LVEF,CO,SV,CI,ventricular septal shortening,left ventricular short axis shortening rate and Tei index in the study group were significantly higher than those in the control group( P < 0. 05). Conclusion The appli-cation of tirofiban in patients with MI during PCI is helpful to improve the degree of myocardial perfusion,and the degree of my-ocardial perfusion is positively correlated with cardiac function.

关键词

替罗非班/心肌梗死/经皮冠状动脉介入术/心肌灌注程度/心功能

Key words

tirofiban/myocardial infarction/percutaneous coronary intervention/myocardial perfusion/cardiac function

分类

医药卫生

引用本文复制引用

赵娟..经皮冠状动脉介入术中冠脉应用替罗非班临床评价[J].中国药业,2017,26(14):61-63,3.

中国药业

OACSTPCD

1006-4931

访问量4
|
下载量0
段落导航相关论文